Unique ID issued by UMIN | UMIN000027701 |
---|---|
Receipt number | R000031547 |
Scientific Title | Multicenter study on clinicopathological features, molecular genetic abnormalities, treatment and prognosis of gastrointestinal malignant lymphomas |
Date of disclosure of the study information | 2017/06/09 |
Last modified on | 2017/06/09 12:21:47 |
Multicenter study on clinicopathological features, molecular genetic abnormalities, treatment and prognosis of gastrointestinal malignant lymphomas
Multicenter study on clinicopathological features, molecular genetic abnormalities, treatment and prognosis of gastrointestinal malignant lymphomas
Multicenter study on clinicopathological features, molecular genetic abnormalities, treatment and prognosis of gastrointestinal malignant lymphomas
Multicenter study on clinicopathological features, molecular genetic abnormalities, treatment and prognosis of gastrointestinal malignant lymphomas
Japan |
Gastrointestinal malignant lymphoma
Medicine in general | Gastroenterology | Hematology and clinical oncology |
Adult |
Malignancy
NO
1) Establish a registration system for patients with malignant lymphoma such as MALT lymphoma, diffuse large B cell lymphoma, follicular lymphoma and NK / T cell lymphoma, which are frequently found in the gastrointestinal tract, at Kyushu university hospital and collaborative research facilities.
2) Verify the data by retrospective examining the clinicopathological features, treatment and prognosis.
3) Evaluate the data by tracking the patient prospectively registered.
Others
Correlation among clinicopathological features, molecular genetic abnormalities, treatment and prognosis
Correlation between treatment and prognosis in gastrointestinal malignant lymphoma
Correlation among clinicopathological features, chromosomal abnormalities, expression of miRNA or mRNA, prognosis, and therapeutic response of gastrointestinal malignant lymphoma
Observational
16 | years-old | <= |
Not applicable |
Male and Female
Patients with gastrointestinal malignant lymphoma diagnosed at Kyushu university hospital and collaborative research facilities from 1970 to 2023.
Patients who reject this research.
700
1st name | |
Middle name | |
Last name | Takanari Kitazono |
Kyushu University
Department of Medicine and Clinical Science, Graduate School of Medical Sciences
3-1-1, Maidashi, Higashi-ku,Fukuoka-shi,Fukuoka.
+81(0)92-642-5261
kitazono@intmed2.med.kyushu-u.ac.jp
1st name | |
Middle name | |
Last name | Yuichi Matsuno |
Kyushu University
Department of Medicine and Clinical Science, Graduate School of Medical Sciences
3-1-1, Maidashi, Higashi-ku,Fukuoka-shi,Fukuoka.
+81(0)92-642-5261
ymatsuno@intmed2.med.kyushu-u.ac.jp
Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University
None
Other
NO
2017 | Year | 06 | Month | 09 | Day |
Unpublished
Open public recruiting
2017 | Year | 03 | Month | 29 | Day |
2017 | Year | 03 | Month | 29 | Day |
(1) In prospective study, written informed consent is obtained after giving an explanation to the patient. In the retrospective study, information on this study is made public on the website after permission of the study.
(2) Register the relevant patient as a subject and obtain the clinical information from the medical record at the time of registration.
(3) Evaluate the data by tracking the patient prospectively registered and clarify the correlation among therapy, prognosis and etc. of gastrointestinal malignant lymphoma.
2017 | Year | 06 | Month | 09 | Day |
2017 | Year | 06 | Month | 09 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031547